2016-02-10 20:31:52 UTC

Pfizer Now Accepting Applications for IBD Research Grant Awards

Feb. 10, 2016

The deadline to submit applications is March 14, 2016.

We wanted to make you aware of a new grant opportunity. Pfizer is now accepting applications for its 2016 Research Awards Program that supports the research of autoimmune diseases, including IBD. The ASPIRE, or Advancing Science through Pfizer Investigator Research Exchange, program, is a competitive, peer-reviewed grants program.

The grants are designed to support researchers in “basic science, and translational and clinical research that advances medical knowledge in the pathogenesis, treatment and prevention of selected diseases,” according to the company's announcement. Pfizer also noted that it is funding research up to a maximum of $150,000 per award, but that larger grants may also be considered in some circumstances.

The deadline to submit applications is March 14, 2016, and the program is only open to U.S. investigators.

Learn more about the ASPIRE awards program.

More on Crohn's Disease

Blog: What Happens When Patients With Crohn’s Disease in Remission Stop Taking Infliximab?

Feb. 21, 2018

Researchers report that fewer than one fifth of patients required surgery. Read more on the AGA Journals Blog.

Attend the AGA Postgraduate Course for Practical, Take Home Information

Feb. 12, 2018

Join us on June 2-3 in Washington, D.C. This course is held in conjunction with Digestive Disease Week® (DDW) 2018.

Building an IBD Specialty Clinic from the Ground Up

Feb. 7, 2018

Gastro One in Tennessee developed an IBD clinic within their practice, which decreased emergency room visits by 70 percent.